The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 3
  • 1
    Diependaal, Johannes Franciscus
    Finance Director born in May 1962
    Individual (1 offspring)
    Officer
    2023-06-30 ~ now
    OF - Director → CIF 0
  • 2
    Heightman, Thomas Daniel
    Company Director born in May 1971
    Individual (2 offsprings)
    Officer
    2024-09-20 ~ now
    OF - Director → CIF 0
  • 3
    700, Us Highway 202/206, Bridgewater, Nj 08807, United States
    Corporate (1 offspring)
    Person with significant control
    2023-06-30 ~ now
    PE - Ownership of shares – 75% or more → CIF 0
Ceased 10
  • 1
    Newcombe-ellis, Alice Vanessa Ilse
    Chief Executive born in November 1982
    Individual (5 offsprings)
    Officer
    2018-05-28 ~ 2021-10-28
    OF - Director → CIF 0
  • 2
    Johnson, Robert Steven
    Chief Executive born in December 1976
    Individual (6 offsprings)
    Officer
    2021-11-11 ~ 2023-06-30
    OF - Director → CIF 0
    Johnson, Robert Steven
    Company Director born in December 1976
    Individual (6 offsprings)
    2023-10-16 ~ 2024-09-20
    OF - Director → CIF 0
  • 3
    Jackson, Stephen Philip, Prof
    Scientist born in July 1962
    Individual (1 offspring)
    Officer
    2017-08-25 ~ 2023-06-30
    OF - Director → CIF 0
    Prof Stephen Philip Jackson
    Born in July 1962
    Individual (1 offspring)
    Person with significant control
    2017-08-25 ~ 2020-12-11
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
  • 4
    Sale, Jamie Lee
    Commercial Director born in January 1977
    Individual (1 offspring)
    Officer
    2023-06-30 ~ 2023-10-31
    OF - Director → CIF 0
  • 5
    Green, Joanna Charlotte Antonia, Dr
    Company Director born in June 1989
    Individual (1 offspring)
    Officer
    2021-10-28 ~ 2023-06-30
    OF - Director → CIF 0
  • 6
    Lewis, William Henry
    Company Director born in September 1968
    Individual
    Officer
    2022-09-28 ~ 2023-06-30
    OF - Director → CIF 0
  • 7
    AHREN INNOVATION CAPITAL LIMITED - 2017-09-23
    15, Queen's Grove, London, United Kingdom
    Dissolved Corporate
    Equity (Company account)
    0 GBP2018-12-31
    Person with significant control
    2018-05-28 ~ 2018-07-19
    PE - Ownership of shares – More than 50% but less than 75% → CIF 0
    PE - Ownership of voting rights - More than 50% but less than 75% → CIF 0
    PE - Right to appoint or remove directors → CIF 0
  • 8
    The Bradfield Centre, 184 Cambridge Science Park, Milton Road, Cambridge, England
    Active Corporate
    Person with significant control
    2018-07-19 ~ 2019-08-19
    PE - Ownership of shares – More than 50% but less than 75% → CIF 0
  • 9
    The Bradfield Centre 184 Cambridge Science Park, Milton Road, Cambridge, England
    Active Corporate (4 parents)
    Equity (Company account)
    3,436,877 GBP2020-12-31
    Person with significant control
    2019-08-19 ~ 2023-06-30
    PE - Ownership of shares – More than 50% but less than 75% → CIF 0
  • 10
    Ground Floor, Le Truchot, St. Peter Port, Guernsey
    Corporate
    Person with significant control
    2019-08-19 ~ 2019-08-19
    PE - Ownership of shares – More than 50% but less than 75% → CIF 0
parent relation
Company in focus

INSMED INNOVATION UK LTD

Previous name
ADRESTIA THERAPEUTICS LTD - 2023-07-03
Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Comprehensive Income/Expense
1,944,564 GBP2021-01-01 ~ 2021-12-31
1,972,834 GBP2020-01-01 ~ 2020-12-31
Total Borrowings
Non-current
0 GBP2021-12-31
0 GBP2020-12-31
Current
0 GBP2021-12-31
0 GBP2020-12-31
Equity
Called up share capital
762 GBP2021-12-31
1,143 GBP2020-12-31
618 GBP2020-01-01
Share premium
15,998,494 GBP2021-12-31
23,997,741 GBP2020-12-31
1,999,598 GBP2020-01-01
Retained earnings (accumulated losses)
4,651,296 GBP2021-12-31
4,066,461 GBP2020-12-31
-366,949 GBP2020-01-01
Equity
0 GBP2021-12-31
20,299,372 GBP2020-12-31
1,266,318 GBP2020-01-01
Average Number of Employees
172021-01-01 ~ 2021-12-31
62020-01-01 ~ 2020-12-31
Total Inventories
3,620 GBP2020-12-31
24,746 GBP2020-01-01
Cash and Cash Equivalents
13,379,196 GBP2021-12-31
6,818,697 GBP2020-12-31
437,357 GBP2020-01-01
Current Assets
13,566,485 GBP2021-12-31
6,879,719 GBP2020-12-31
568,354 GBP2020-01-01
Total assets
14,080,645 GBP2021-12-31
7,291,847 GBP2020-12-31
646,515 GBP2020-01-01
Total liabilities
8,406,665 GBP2021-12-31
645,585 GBP2020-12-31
13,356 GBP2020-01-01
Net Assets/Liabilities
5,673,980 GBP2021-12-31
6,646,262 GBP2020-12-31
633,159 GBP2020-01-01
Equity
Called up share capital, Restated amount
381 GBP2020-12-31
Retained earnings (accumulated losses), Restated amount
-1,353,366 GBP2020-12-31
Restated amount
6,646,262 GBP2020-12-31
Profit/Loss
Retained earnings (accumulated losses)
-972,282 GBP2021-01-01 ~ 2021-12-31
-986,417 GBP2020-01-01 ~ 2020-12-31
Profit/Loss
-972,282 GBP2021-01-01 ~ 2021-12-31
-986,417 GBP2020-01-01 ~ 2020-12-31
Comprehensive Income/Expense
Retained earnings (accumulated losses)
-972,282 GBP2021-01-01 ~ 2021-12-31
-986,417 GBP2020-01-01 ~ 2020-12-31
Issue of Equity Instruments
Called up share capital
72 GBP2020-01-01 ~ 2020-12-31
Issue of Equity Instruments
6,999,520 GBP2020-01-01 ~ 2020-12-31
Equity - Income/Expense Recognised Directly
Called up share capital
72 GBP2020-01-01 ~ 2020-12-31
Equity - Income/Expense Recognised Directly
6,999,520 GBP2020-01-01 ~ 2020-12-31
Property, Plant & Equipment - Depreciation Expense
245,181 GBP2021-01-01 ~ 2021-12-31
80,721 GBP2020-01-01 ~ 2020-12-31
Wages/Salaries
968,183 GBP2021-01-01 ~ 2021-12-31
368,794 GBP2020-01-01 ~ 2020-12-31
Staff Costs/Employee Benefits Expense
1,170,232 GBP2021-01-01 ~ 2021-12-31
413,315 GBP2020-01-01 ~ 2020-12-31
Director Remuneration
177,370 GBP2021-01-01 ~ 2021-12-31
157,383 GBP2020-01-01 ~ 2020-12-31
Other Interest Receivable/Similar Income (Finance Income)
4,567 GBP2021-01-01 ~ 2021-12-31
758 GBP2020-01-01 ~ 2020-12-31
Interest Payable/Similar Charges (Finance Costs)
-10,924 GBP2021-01-01 ~ 2021-12-31
-4,700 GBP2020-01-01 ~ 2020-12-31
Tax Expense/Credit at Applicable Tax Rate
-184,734 GBP2021-01-01 ~ 2021-12-31
-187,419 GBP2020-01-01 ~ 2020-12-31
Property, Plant & Equipment - Gross Cost
Plant and equipment
475,530 GBP2021-12-31
151,263 GBP2020-12-31
80,696 GBP2020-01-01
Office equipment
61,123 GBP2021-12-31
20,662 GBP2020-12-31
16,168 GBP2020-01-01
Property, Plant & Equipment - Gross Cost
858,765 GBP2021-12-31
466,204 GBP2020-12-31
96,864 GBP2020-01-01
Furniture and fittings
31,155 GBP2021-12-31
3,322 GBP2020-12-31
Other
290,957 GBP2021-12-31
290,957 GBP2020-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
130,438 GBP2021-12-31
48,587 GBP2020-12-31
14,992 GBP2020-01-01
Office equipment
19,429 GBP2021-12-31
8,141 GBP2020-12-31
3,711 GBP2020-01-01
Property, Plant & Equipment - Accumulated Depreciation & Impairment
344,605 GBP2021-12-31
99,424 GBP2020-12-31
18,703 GBP2020-01-01
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment
81,851 GBP2021-01-01 ~ 2021-12-31
33,595 GBP2020-01-01 ~ 2020-12-31
Furniture and fittings
6,563 GBP2021-01-01 ~ 2021-12-31
265 GBP2020-01-01 ~ 2020-12-31
Office equipment
11,288 GBP2021-01-01 ~ 2021-12-31
4,430 GBP2020-01-01 ~ 2020-12-31
Other
145,479 GBP2021-01-01 ~ 2021-12-31
42,431 GBP2020-01-01 ~ 2020-12-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
245,181 GBP2021-01-01 ~ 2021-12-31
80,721 GBP2020-01-01 ~ 2020-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Furniture and fittings
6,828 GBP2021-12-31
265 GBP2020-12-31
Other
187,910 GBP2021-12-31
42,431 GBP2020-12-31
Finished Goods/Goods for Resale
3,620 GBP2020-12-31
Prepayments/Accrued Income
Current
34,965 GBP2021-12-31
24,027 GBP2020-12-31
Trade Creditors/Trade Payables
Current
318,021 GBP2021-12-31
222,846 GBP2020-12-31
Accrued Liabilities
Current
397,522 GBP2021-12-31
184,653 GBP2020-12-31
Taxation/Social Security Payable
Current
41,227 GBP2021-12-31
Other Remaining Borrowings
Non-current
108,583 GBP2020-12-31
Current
95,423 GBP2021-12-31
129,287 GBP2020-12-31
Total Borrowings
95,423 GBP2021-12-31
237,870 GBP2020-12-31
Par Value of Share
Class 1 ordinary share
0.012021-01-01 ~ 2021-12-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
10,811 shares2021-12-31
10,811 shares2020-12-31
Par Value of Share
Class 2 ordinary share
0.012021-01-01 ~ 2021-12-31
Number of Shares Issued (Fully Paid)
Class 2 ordinary share
20,078 shares2021-12-31
20,078 shares2020-12-31
Par Value of Share
Class 3 ordinary share
0.012021-01-01 ~ 2021-12-31
Number of Shares Issued (Fully Paid)
Class 3 ordinary share
7,216 shares2021-12-31
7,216 shares2020-12-31
  • INSMED INNOVATION UK LTD
    Info
    ADRESTIA THERAPEUTICS LTD - 2023-07-03
    Registered number 10934416
    B960 Building Babraham Research Campus, Cambridge CB22 3FH
    Private Limited Company incorporated on 2017-08-25 (7 years 10 months). The company status is Active.
    The last date of confirmation statement was made at 2024-09-02
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

qrcode

Privacy notice

Terms and conditions

© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.